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ABSTRACT

Parkinson’s disease (PD) is a neurodegenerative movement disorder that progresses
gradually over time. The onset of symptoms in people who are suffering from PD can vary
from case to case, and it depends on the progression of the disease in each patient. The PD
symptoms gradually develop and exacerbate the patient’s movements throughout time. An
early diagnosis of PD could improve the outcomes of treatments and could potentially
delay the progression of this disorder and that makes discovering a new diagnostic method
valuable. In this study, I investigate the feasibility of using a machine learning (ML)
approach to classify PD patients from a healthy group. A set of plasma samples were
collected from both PD patients and healthy people. Then the data were processed in a
custom-designed capillary zone electrophoresis (CZE) system. CZE allows us to study
metabolomics, which is the chemical processes and comprehensive analysis of small
molecules in regard to metabolism within an organism such as a cell or body fluids like
plasma. Metabolic profiling can demonstrate changes in the composition and therefore it
can potentially reflect an underlying condition or may provide valuable information for
disease diagnosis. After preprocessing the generated electropherograms or output data
from the CZE system, I developed and applied various machine learning algorithms to
distinguish the PD samples from the healthy samples based on the biomarkers extracted
ii

using the CZE system. Our experimental results demonstrate that there are clearly different
features in two groups of samples. Therefore, it was possible to reach the classification
accuracy of 94% in a very small set of samples.
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CHAPTER ONE: INTRODUCTION

1. Parkinson’s Disease

Parkinson’s disease (PD) is a progressive neurodegenerative disorder that causes
movements malfunctions. It is possible people start showing PD symptoms at an early age,
but the average age is around 60. In the United States, it is estimated that the prevalence of
PD reaches nearly 1 million at present. This number is predicted to reach 1.2 million cases
by 2030 [1]. The symptoms develop gradually, and they progress and get worse over time.
In PD, specific neurons start to malfunction, and gradually it will lead to the death
of these vital nerve cells [2]. The loss of these neurons that their presence is essential to
produce a neurotransmitter called dopamine. Dopamine is responsible for controlling
movement and coordination, and the decrease of its amount causes abnormal brain activity
such as impaired movement. The progress of PD exacerbates dopamine production in the
brain, leaving a person unable to control movement normally [3].
However, the exact cause of PD is unknown; researchers believe genetic mutations
and environmental triggers could play a role.
Primary motor signs of Parkinson’s disease include the following:
•

Tremor of the hands, arms, legs, jaw, and face

•

Bradykinesia or slowness of movement
1

•

Rigidity of the limbs and trunk

•

Postural instability or impaired balance and coordination.

There is no specific test to diagnose Parkinson's disease. Neurologists will diagnose
PD based on the patient’s medical history, evaluations of signs and symptoms, and a
neurological and physical examination [4], [5]. Due to the lack of a reliable test, there is
always a possibility for misdiagnosis. Moreover, the onset of PD is currently determined
when the motor symptoms start to emerge but there is evidence suggesting that when first
motor symptoms manifest about 50% of substantia nigra dopaminergic neurons are
compromised [6], [7].
Even though there is no cure for PD, there are two main types of treatment to
improve the symptoms. Firstly, administrating carbidopa-levodopa can help to produce
dopamine in the brain and compensate for the lack of it. Carbidopa will help to prevent the
degeneration of levodopa in the bloodstream [8]. This treatment is for the early stages of
PD and by the progression of the disease, levodopa loses its effectiveness. The other
treatment is deep brain stimulation (DBS). DBS is an invasive method and it requires
surgery. A surgeon will put electrodes in a specific area of the brain, called the subthalamic
nucleus and it has proven that the stimulation can improve the symptoms significantly [9].

2

2. Metabolomics

The study of chemical processes and comprehensive analysis of small molecules in
regard to metabolism within an organism such as a cell or body fluids like plasma refers to
metabolomics. Metabolomics provides unique chemical fingerprints and profiles
associated with distinguishing chemical processes [10], [11]. Metabolic profiling can be
utilized to demonstrate changes in the composition of the metabolites, and therefore it can
potentially reflect an underlying condition or may provide valuable insights about it. Due
to recent advances, metabolomics is considered an emerging technology that delivers a
powerful tool for precision medicine and provides a direct "functional readout of the
physiological state" of an organism [10]. Different analytical techniques have been widely
exploited in metabolomics, such as Gas Chromatography (GC), Liquid Chromatography
(LC) interfaced with Mass Spectroscopy (MS) as well as Nuclear Magnetic Resonance
(NMR) Spectroscopy and Capillary Electrophoresis [12].

3. Capillary Zone Electrophoresis

Capillary Zone Electrophoresis is described as a technique of detecting specific
particles, sample ions, such as different molecules, proteins, peptides, and nucleic acids
within a larger unknown compound in a narrow bore (25-100 micron) capillary tube filled
with an electrolyte solution (buffer) [13]. The buffer solution provides conductivity
through the capillary tube allowing the flow of current.
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By applying high voltage across the capillary, the generated current which flows
through the tube results in the separation of the injected compound. The sample solution
(typically 1-20 nL) is placed at the end of the capillary tube away from the detector. The
light detector, photomultiplier, is somewhere near the capillary right before it enters the
buffer reservoir that is connected to the ground. The capillary tube ends from both sides
are dipped into reservoirs containing electrolyte solution and high-voltage electrodes. One
electrode from a cable leads to the output of the high-voltage power supply, whereas the
other one is connected to the ground cable. To have the best conductivity, the electrodes
usually are made of platinum [14].
The sample solution goes through a preparation process. It is combined with a
biomarker, fluorescein isothiocyanate (FITC), that can show the volume of each particle.
The measurements happen by finding the intensity of the glowing fluorescent, resulting
from the laser when it hits the capillary. The generated plot of detector response through
time is termed an electropherogram.
The system consists of different parts that are described in the following:
•

Capillary: It is a long, very small tube with a length and diameter of about
60 cm and 25 microns respectively. The capillary has a yellow coating
which should be removed where the laser hits to be transparent for it.

•

Laser: it is a solid-state continuous waveform laser with a 488nm
wavelength.

•

Photomultiplier: to measure the light intensity resulting from laser hitting
the capillary.
4

•

Pump: there is a pump for conditioning the capillary and the injection of the
sample.

•

Valves: there are two valves that control the injection and conditioning.

•

Pressure chamber: this keeps the pressure constant for the different runs of
the samples.

•

Buffer reservoir: this reservoir containing the buffer provides an
environment for the buffer inside the capillary to be connected to the ground
and keep the circuit closed for the current.

•

Power supply: It is responsible for providing a high voltage of 27000 volts.

The block diagram of the CZE is depicted in Figure 1.1.

Figure 1.1 CZE block diagram
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3.1 Electrophoresis

Electrophoresis refers to the movement of sample ions under the influence of an
electric field [14], [15]. The applied voltage causes ions to move toward the appropriate
electrode and pass through the detector. The size and number of ionic charges affect the
migration rate or mobility resulting in different shapes of time series. For instance, a
smaller ion moves faster than a larger one considering both have the same number of
charges, or an ion with higher charges moves faster than an ion in the same size with only
one charge. The ionic mobility is described as Equation 1.1
𝜇𝐸 =

𝑞
6𝜋

𝜂𝑟

1.1

Where 𝜇𝐸 is electrophoretic mobility, 𝑞 number of charges, 𝜂 solution viscosity, and 𝑟
radius of the ion.
Therefore, in electrophoresis of solutions of different ions, the smaller particle will
appear sooner in the plot of detector response.
Furthermore, the electrophoretic velocity (Equation 1.2) of the ions is related to their
mobilities and the magnitude of the applied electric field.
𝑣 = 𝜇𝐸 𝐸

1.2

Where 𝑣 is the velocity of the ion, and is 𝐸 the applied electric field.
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3.2 Electro-Osmotic Flow (EOF)

The applied voltage across the capillary causes a flow of solution due to the
presence of an electrolyte. This solution flow pushes solute ions along the capillary toward
the same direction as the flow generated by the applied voltage. This flow happens due to
the ionization of the acidic silanol groups on the inside of the capillary because of being in
contact with the buffer solution. At high pH, these groups are separated, resulting in a
negatively charged surface followed by cations appearing near the surface to maintain
electroneutrality. The applied voltage across the capillary pushes these cations towards the
cathode (Figure 1.2). Due to the presence of water molecules solvating the cations, a flow
of solution along the capillary occurs due to cations movement (Figure. 1.2). This effect
refers to as an "electric pump."
The flow intensity is dependent on the charge on the capillary, the buffer viscosity,
and the dielectric constant of the buffer, which is shown in Equation 1.3:
𝜇𝐸𝑂𝐹 =

𝜀𝜁
𝜂

1.3

where 𝜇𝐸𝑂𝐹 = "EOF mobility," 𝜂 = viscosity, and ζ = Zeta potential (charge on the
capillary surface).
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Figure 1.2 Electroendosmosis flow [14]

The ζ potential is highly affected by the ionization of the acidic silanols, resulting
in the EOF intensity's dependence on electrolyte pH. Below pH 4, since the ionization is
small, the EOF flow rate is neglectable. On the contrary, above pH 9, the silanols are
completely ionized, leading to a strong EOF [16]. The relation of pH and EOF is depicted
in Figure 1.3. The EOF level reduces with the increase in electrolyte concentration while
the ζ potential is diminished.
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Figure 1.3 Changes of EOF based on pH [14]

The separation occurs due to the presence of EOF, which allows detection of both
cations and anions within a single analysis, due to sufficient level of EOF at pH 7 and
above, to push anions towards the cathode regardless of their charge. The electropherogram
results from a study of a mixture of cations, neutral compounds, and anions. Each peak
represents a compound and the corresponding migration time for that peak is when the
compound passes through the detector.

9

Since the smaller anions show more resistance against the EOF, they are detected
later than anions with lower mobility. Additionally, anions with higher charges move more
strongly against the EOF, and therefore they will be detected later. Thus, pH is considered
as the most critical operating parameter since it has significant impacts on the separation
of the ionic particle by affecting both solute charged level and the EOF intensity.
Finally, the migration time of a solute is defined with regard to the mobility of the
solute and its intensity. Equation 1.4 describes the apparent mobility equation, which is
measured from the migration time.
𝑙𝐿

𝜇𝐴 = 𝜇𝐸 + 𝜇𝐸𝑂𝐹 = 𝑡𝑉

1.4

where l = length along the capillary (cm) to detector, V = Voltage, and L = total length
(cm) of the capillary.

4. Capillary Electrophoresis Background

For disease diagnosis, it is crucial to discover the associated biomarkers [17] and
proteins and peptides constitute one of the essential groups of biomarkers. The various
approaches that have been used to detect these biomarkers are not without difficulties since
they require the handling of real samples [18].
We can find these biochemical biomarkers in tissues or biological fluids such as
blood and cerebrospinal fluid (CSF). For a diagnosis purpose, the physiological process of
the disease affects the selection of the biological fluid. Therefore, the patient’s disease state
can be defined by the concentration of the biomarkers in the collected sample.
10

There are different strategies reported for capillary electrophoresis (CE) analysis in
diagnosis which is developed by using body fluids. By using CE, not only could we detect
biomarkers but also quantize them, and this technique is highly advantageous since it
provides high efficiency and resolution with a small amount of sample volume. Also, it is
possible to accomplish high sensitivity when it is coupled with laser-induced fluorescence
detection (LIF) [19] or mass spectrometry (MS). However, dealing with biomarker analysis
by CE is not without difficulties. Firstly, the complexity of the sample matrix and then their
low concentration could play an important role in this analysis.
For example, a very common biological fluid is blood containing many proteins in
very different concentrations. This could cause problems due to interfering substances that
could deteriorate the separation and also because of potential interaction between the
targeted substance and the rest of plasma proteins leading to changing the accuracy.
Proteins and peptides, additionally, have a tendency to interact with the surface of the
silicone capillary affecting the resolution and sensitivity of the system. To keep the system,
different functional actions must be taken in addition to the initial CE separation system.
Biological fluids containing biomarkers consist of proteins and compounds that
could lead to many potential interferences due to similar behavior during the CE analysis
process. Therefore, prior to running the sample, a preparation step must be performed in
order to reduce or eliminate the adversarial factors that could potentially interrupt CE
analysis. The preparation process not only helps to get rid of the non-interesting
compounds but also to magnify the biomarker effects by increasing their concentration of
them.
11

The most common body fluids that are used for protein analysis are plasma, serum,
and cerebrospinal fluid. Protein analysis from these fluids is complicated since it requires
sample cleanup before other steps. Many methods have been presented for the sample
treatment to extract, isolate, filtrate, or concentrate the targeted substance from these body
fluids. This study uses liquid-liquid-based extraction techniques to eliminate interfering
substances in the plasma, such as centrifugation or precipitation. The steps for sample
treatment are thoroughly explained in the next chapter.

5. Literature Review

The applications of artificial intelligence (AI) and machine learning (ML) have
been gaining more popularity in biomedical research. Most research is focused on medical
diagnosis and detection of different stages in different diseases. In spite of the fact that
several studies have been carried out to explore biomarkers associated with PD, a reliable
test to diagnose PD remains unknown [20]. Presently, most diagnoses are made after the
onset of motor symptoms, and the emergence of symptoms occurs once the damage has
progressed drastically. Despite the vast knowledge of the neuropathology of PD, an
accurate test for diagnosing PD remains challenging, especially in the PD early stages [21].
Even though many studies are being conducted on developing and validating
biomarkers for PD, the success rate remains far from satisfactory [22]. Thus, the discovery
of diagnostic biomarkers is necessary to provide enough time to intervene by early
diagnosis at the onset of the disorder and affect the efficiency of the course of treatments.
12

As mentioned, one of the most well-known techniques to detect and identify
different chemical compounds is capillary electrophoresis (CE). This analytical tool
presents a simple, cost-efficient, and fast separation method that can be exploited in the
analysis and detection of different components and particles of larger unknown
compounds. The applications of CE have been rapidly growing in a chemometric study,
such as diagnosis of diabetes [23] or quantifying the amount of polyamines [24] which can
be an important way to understand the progression of PD. Since CE can help measure the
amount of a particular component within a given chemical compound, it has been used to
quantify the amount of putrescine in red blood cells of PD patients. It is shown that the
levels of putrescine concentration were significantly higher for PD patients compared to
healthy people [24].
Additionally, it has been demonstrated that the CE can offer a classification method
for different chemical compounds [25]. They propose an ML approach to classify the
quality of olive oil using CZE with UV detection to generate electropherograms of three
different groups of samples. This study shows that using CE makes it possible to reach a
high classification accuracy for separating the various quality of olive oil.
Furthermore, in toxicology, some research has been conducted for using pattern
recognition in the classification of urine samples. They used different ML algorithms for
determining the type of cadmium dosage, acute or chronic. The ML models were trained
based on the urine profiling that CE offers [26]. Capillary electrophoresis has been used
on urine profiling for cancer patients as well [27]. They have shown that by using a neural
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network, it is possible to separate normal people from patients who are suffering from
different kinds of cancer.
To the best of our knowledge, there has been very little work on pattern recognition
and machine learning for capillary electrophoresis analysis for PD research. As mentioned
[9], PD patients could have a higher concentration of putrescine in their blood cells.
Furthermore, in another study, they show that spermine levels and also sperminespermidine ratio were significantly declined in the PD group [28]. Therefore, we can
assume there are other molecules and chemical components that their concentration can be
affected by PD. This study aims to investigate the application of CE further and by using
the whole electropherogram instead of a few peaks in the signal, we want to dig deeper into
differences in PD patients and healthy people.
In this study, before data analysis, the plasma samples went through a preparation
process. Next, I run all the samples based on a designed protocol and the electropherograms
of the plasma samples are acquired by using CZE. Firstly, the corresponding peaks across
samples are detected and they are used to do a classification between the PD group and
healthy people. Finally, the classification algorithms are developed using whole
electropherograms. Several steps are taken to preprocess the data before analysis, namely
noise reduction and baseline correction.

14

6. Thesis Goals and Impacts

As discussed earlier, there is no reliable test to determine whether someone has PD
or not based on blood biomarkers and the available methods are physical exam and
evaluation of brain imaging. However, there is a high chance of misdiagnosis in the
mentioned methods. The main goal of this thesis is to provide a way for early and accurate
diagnosis of PD patients. It is shown that electropherogram signals contain vital
information about the contents of a compound. In other words, the thesis aims to investigate
the correlation of patterns associated with PD and find a biomarker for this disease. This
could help classify healthy people and detect anomalies in their samples in the early stage
of the disease using machine learning algorithms. By developing a data analysis pipeline,
I extracted features from electropherograms and used them to do the classification of the
dataset into the two groups of PD and NC.

15

CHAPTER TWO: DATA ACQUISITION

1. Subjects

For collecting data, the samples should be prepared. The plasma sample was taken
from 22 people, with 11 subjects for the PD group and 11 subjects for normal control (NC).
The demographic information of each subject is shown in Table 2.1 and Table 2.2.
Table 2.1 Normal control group

Study ID

SEX

AGE

C-1

male

62

C-2

male

60

C-3

female

64

C-4

female

65

C-5

female

62

C-6

female

64

C-7

female

61

C-8

female

61

C-9

female

68

C-11

female

72

C-12

female

64
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Table 2.2 PD subjects

DISEASE DURATION
Study ID

SEX

AGE
since diagnosis (years)

P-1

female

70

7

P-2

male

61

10

P-3

female

67

8

P-4

male

71

5

p-6

female

61

7

p-7

male

67

8

p-8

male

69

8

p-9

male

60

7

p-10

female

68

8

p-11

female

62

6

p-12

female

71
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The plasma samples of subjects were kept in the freezer at -80 Celsius degree temperature.

2. Sample Preparation

After thawing samples at room temperature, each plasma sample goes through a
preparation process to be ready to be run in the systems. This step is essential to remove
any interfering substance from the samples. A brief explanation of this process is given:
17

•

Adding acetonitrile to samples to precipitate the proteins in plasma.

•

Centrifuging the samples to separate the plates in plasma.

•

Extracting the clear supernatant from centrifuged plasma.

•

Adding Fluorescein isothiocyanate (FITC), which is mixed with carbonate
buffer and acetone to derivatize the samples with equal volume as the
samples.

•

Leave the samples for 24 hours to be combined with FITC.

To prepare the dye to be used as biomarkers, the Fluorescein isothiocyanate (FITC)
was mixed with acetone with a dilution factor of 1mg per 1ml. After mixing it well, the
solution was added to the same amount of carbonate buffer. Next, the dye needs to be
filtered before adding to derivatize the samples.
After preparing the samples, it is crucial to dilute them with the correct dilution
factor to get the most applicable spectrum of samples. Five microliters of each sample were
taken and added to 95 microliters of H2O for these samples. Then 25 microliters of the
new solution were taken and mixed with 12.5 microliters of H20. The different dilution
factors have impacts on the generated spectrum. The high concentration of FITC without
proper dilution will cause saturation of the signals in most peaks, making it hard to
distinguish between them.
There are two different buffers that are used, the carbonate buffer and the borate
buffer. The carbonate buffer was resulted by combining 200mM sodium carbonate and
200mM sodium bicarbonate. The amount of each solution is 5 ml and 5 ml, respectively.
Then 90 ml of H2O was added to make 100 ml of 20 mM carbonate buffer. And 40mM
18

sodium tetraborate decahydrate and 20mM sodium dodecyl sulfate was used in equal
volume to make the borate buffer. The carbonate buffer was used in the dye, and then for
running the samples, the capillary was filled with the borate buffer.

3. Data Acquisition

For running the samples, the system must be prepared. Before injecting the sample
to the capillary, the capillary was conditioned with 0.1 mM NaOH. Then it was rinsed with
water. For these processes, the capillary was washed using positive pressure by applying
constant pressure on the syringes containing NaOH and H2O for two minutes. Next, the
capillary was filled with a buffer that provides its current conductivity.
The protocol to run a sample is as described:
•

Condition the capillary with 0.1mM NaOH for two minutes with positive
pressure or 8 minutes with negative pressure.

•

Rinse with H2O for two minutes with positive pressure or 8 minutes with
negative pressure.

•

Filled the capillary with BF for two minutes with positive pressure or 8
minutes with negative pressure.

•

Inject the sample for 2 sec using the pressure chamber and the pump.

•

Inject the BF for 2 sec using the pressure chamber and the pump.

•

Activate the power supply a let it run for about 40 minutes.

19

The signal acquired by the photomultiplier represents the amount of some specific
molecules within the samples. By mixing the plasma samples with FITC, the particles of
the plasma get attached to the FITC. After applying high voltage across the capillary, the
particles start to separate from each other due to the polarity of molecules. The negative
particles go towards the cathode and the negative ones towards the anode. There are some
neutral molecules that will be pushed by the Na ion existing inside the buffer since Na is
moving towards the anode. This difference between polarities of molecules causes the
electropherogram to have three groups of peaks. The first group has a negative charge, the
second group is neutral, and the last one is positive.
When these molecules pass the laser, the fluorescent starts to glow, providing a
phenomenon that the photomultiplier can catch. The intensity of this light shows the
amount of FITC attached to the molecules, which can quantize the amount of the
compartments.
The acquired electropherograms from two NC and PD groups samples are depicted
in figures 2.1 and 2.2, respectively.

20

Figure 2.1 Electropherogram of a healthy person

Figure 2.2 Electropherogram of a PD patient
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The concentration of plasma samples in the newly prepared solution is essential to
give the most detailed information about each sample. For instance, one of the samples of
the PD group was rum three times with three different dilution factors. The first sample is
prepared by mixing 5 ul of the original solution and 95 ul of H2O. The second one uses 25
ul of the previously described solution with 12.5 ul of H2O. For the final solution, another
25 ul of the same solution is used with the difference in the amount of water added, which
is 25 ul. The spectrums of these solutions, the first solution (blue), the second solution
(purple), and the last solution (green) are shown in figures 2.3 and 2.4.

Figure 2.3 Electropherogram of a PD patient with different concentrations of FITC
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Figure 2.4 Area of interest; Electropherogram of a PD patient with different concentration of FITC

By adding more water to the samples, we can decrease the number of saturated peaks,
which is important to show the differences between any other of them. However, more
water can cause a decrease in the amplitude of smaller peaks. Therefore, the concentration
of the second solution is considered as the optimal diluted solution.

4. Sample Spiking

Each peak represents a different molecule. To find the targeted molecule, first, the
plasma sample was run alone. Next, we inject the sample for two seconds along with the
injection of a specific molecule right after that. In this way, the concentration of each
molecule inside the capillary drops except for the molecule that was injected separately.
By comparing the newly acquired electropherogram with the spectrum of the sample, we
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can identify the location of the specific molecule among all the peaks. For instance, in
Figure 2.5, the spectrum for the PD sample of subject six is shown along with the spectrum
of the same sample with an injection of Alanin for 2 seconds.
As can be seen in figure 2.2, at a time of about 7.2 minutes, there is only an increase
in the amplitude of the peaks. Thus, this peak represents the arginine.

Figure 2.5 Electropherogram of a PD patient compared to the Electropherogram of the same sample with
Alanin injection
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Figure 2.6 Peak associated with Alanin

This relationship is the reason why the electropherogram contains crucial information and
can be utilized to diagnose distinctive diseases. Since PD has different symptoms and they
can have impacts on the metabolism of the body’s organs, the concentration of each
molecule in the plasma could change based on the severity of the PD in the patients. In this
method, by taking all common peaks into consideration, we can find the pattern associated
with PD and use it for early diagnoses.
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CHAPTER THREE: DATA PREPROCESSING

1. Denoising

For noise suppression, two different methods are carried out depending on the
accuracy of the algorithm to preserve the vital information of the electropherograms.
Firstly, noise suppression was accomplished by using wavelet transform Figure 3.1. Prior
to further analysis the wavelet decomposition of the signal at level 7 with ‘Symlet4’ was
computed.

Figure 3.1 Wavelet coefficients in different level
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After thresholding the detail coefficients, the denoised signal was reconstructed
using the original coefficients of level 7 and the modified detail coefficients of level from
1 to 7.
Secondly, a moving average filter is used to remove the noise in the signals. The
procedure is carried out by sweeping a window of a specific length through the signal and
taking the average of the data points within the window. It was shown that the moving
average performs better over the wavelet to keep the value of peaks in the
electropherograms.

2. Baseline Correction

Due to changes in experimental conditions such as possible residue of the dye inside
the capillary and erosion of the inner side of the capillary through time, the signal can drift
with different experiments. To keep the shape of the electropherogram consistent, it is
necessary to remove the bias in the baseline. For the baseline correction, the signal passes
a low-pass filter to omit small fluctuations in order to find the prominent peaks of the
signals. The valleys of the signals were determined by using the reversed signal and
detection of peaks of specific height in the new signal. Then by using a cubic interpolation
among the detected valleys, a baseline was drawn. Finally, the fitting curve was subtracted
from the original electropherogram to correct the baseline.
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3. Peak Detection

Detection of peaks in the electropherogram is important since each peak represents
a molecule in the chemical compound. The peak was detected by using the first derivation
of the signal and adding some restrictions to obtain the relevant ones, such as the height
and minimum distance of two adjacent peaks.
In order to find the corresponding peaks, an algorithm called Dynamic Time
Warping (DTW) was used. In DTW, the distance between all two pairs of peaks is
calculated and, based on those pairs; these calculations result in a matrix of distances for
all peaks. In this matrix, a path that has the shortest distance for all pairs of peaks is the
answer to the alignment [29].
With these links that exist between each pair, the path between two corresponding
peaks is known, and by assigning each peak to the corresponding point in the other signal
the aligned signals are obtained.

4. Feature extraction

For the feature extraction, since the corresponding peaks across all
electropherograms are found, by calculating the height and the area under each peak we
have a vector of features that can be used to classify the spectrums into two groups. This
process is described in more detail in the next chapter for each different dataset.
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5. Software Implementation

The code for all of the above parts was implemented on MATLAB and a graphical
user interface was developed to provide a user-friendly environment for manipulating the
peaks.

Figure 3.2 Graphical interface of the peak detection pipeline
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CHAPTER FOUR: CLASSIFICATION

1. Algorithms for Binary Classification

The goal of this thesis is to classify electropherograms into two different groups.
Therefore, a binary classifier is needed. Several methods are evaluated for this
classification, such as support vector machine (SVM), random forest, k-nearest neighbors
algorithms, and deep learning.

1.1 Support Vector Machine (SVM)

The SVM has been used widely in pattern recognition applications. SVM finds the
optimal hyperplane that separates the two training classes [30]. As can be seen in figure
4.1a there are a number of potential hyperplanes. The support vectors refer to the samples
of a class that is in the closest distance of the other class, and the margin is defined by the
distance between the hyperplane and the support vectors. SVM chooses the hyperplane
with the largest margin of separation which can be seen in Figure 4.1b.
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a

b

Figure 4.1 SVM chooses the maximum margin various among potential hyperplanes

Given a training set of n points with the following form
(𝑥1 , 𝑦1 ), … , (𝑥𝑛 , 𝑦𝑛 )
Where the 𝑦𝑖 indicates in which classes xi belongs. In this algorithm, the goal is to find the
maximum-margin hyperplane that can divide the points xi into different groups. Any
hyperplane that can satisfy the following (Equation 4.1) can split the points into different
classes.
𝑤 𝑇 𝑥𝑖 − 𝑏 = 0

4.1

where w is the normal vector of the hyperplane.
SVM solves the following optimization problem (Eq 4.2) for the given X, Y vectors.
by minimizing
1
𝑛

∑𝑛𝑖=1 max(0, 1 − 𝑦𝑖 (𝑤 𝑇 𝑥𝑖 − 𝑏)) + 𝜆‖𝑤‖2
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4.2

1.2 Random Forests

Random decision forests are an ensemble learning method for classification that
operates by constructing a large number of decision trees at training time. The classification
output of the model is chosen by the output class of most decision trees [31].
The RF functions are based on decision trees, a type of ML algorithm for
supervised learning. In decision trees, the data is continuously split into different parts
according to a certain parameter. These parameters could be interoperated as features to
train the model. For training a random forest model, many decision trees will be created
and the result of the majority of models determines the output class of the algorithm.

1.3 K-nearest Neighbors

K-nearest neighbors (KNN) is a type of classification where the algorithm relies on
the distance of each set of points from each group [32]. In this classification algorithm, k
is a user-defined constant which determines the number of training samples closest to the
query point. An unlabeled vector (a query point) is classified by assigning the label of the
most frequent class among the group of k training samples nearest to that vector.
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Figure 4.2 KNN classification for two groups of samples

1.4 Deep Learning for the Classification

Most of the previous research on capillary electrophoresis analysis was based on
using traditional machine learning to classify data into different classes. The problem with
those approaches is the need for aligning signals prior to starting using classification
algorithms. In this method, the alignment process was disregarded by training a deep model
that is not sensitive to the timing of electropherograms.
This model, first, was developed on a different dataset. The electropherograms of
this dataset are acquired by running the eye chamber fluid. First, Pancreatic islets of
diabetic subjects were implanted in the eye chamber of mice. Next, the fluid inside the eye
chamber was extracted and was derivatized similar to parkinsonian subjects.
The samples belong to two groups. The first group describes the mice that rejected
the islets, and the other group belongs to mice that tolerated the implants. A sample of the
33

data for each group is shown in Figure 4.3. Ceballos et al. performed the classification
based on a machine learning approach [33]. The goal of developing this new deep learning
model is to be able to classify electropherograms correctly without the need for alignment.
To develop this new model, a convolution neural network (CNN) is connected to
the recurrent neural network (RNN), providing features for long short-term memory
networks (LSTM) [34], [35]. Since this network is not stable during different runtimes,
five similar architectures of the CNN-LSTM network are aggregated. Finally, a fully
connected network is used to convert the outputs of these five networks into two classes.
The neural network is depicted in Figure 4.4.

Figure 4.3 The electropherograms of rejected (orange) and tolerant (blue) group
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Figure 4.4 Schematic of the deep learning model

Wavelet transform is also used to transfer the input signal to a shorter length in
order to be fed to the network. The coefficients of the 5th level of ‘Symlet4’ are used for
wavelet transformation.
For making the DL model insensitive to the timing of the input signal, data
augmentation was used. In this method, several electropherogram signals are generated by
shifting the signal to the right and left. Using those newly generated signals to train the DL
model means there is no need to align the electropherograms before feeding them to the
model. The accuracy that was achieved for the original samples from the eye chamber
fluids by using this new dl model was 91%.

2. Results

2.1 Using the Integrated Peaks

A total of 30 peaks were selected based on the observation of all electropherograms
and the height and the area under the curve of each peak were calculated. Firstly, All the
extracted features are used in the classification problem. Furthermore, to improve the result
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of machine learning algorithms, based on the mean and the standard deviation of the height
and the area under each peak, 19 peaks were handpicked and were used as features for
training the ML algorithm. The features are selected based on the statistical hypothesis test
(t-test).
The calculation of height and area under each peak results in the first set of features.
Therefore, a total number of 49 features are exploited to be used in the machine learning
algorithms. The highest accuracy that was reached using all integrated peaks was 68%.
This was achieved by using SVM algorithms as the classifier with linear kernel. To
improve the results, a feature reduction algorithm, principal components analysis (PCA),
is performed on the features, resulting in an accuracy of 72 percent with the same ML
algorithms. Furthermore, based on the p-value of features in each group, 19 peaks were
selected. This new approach helped to reach the accuracy of 91 percent. For classification,
the three methods described earlier are used. As it is shown, the best result belongs to SVM.
In each time, the model was trained based on 11-fold cross-validation 100 times. The
confusion matrix, accuracy, sensitivity, and specificity for SVM, Random Forest, and KNN
are reported respectively.
The c value in SVM is 3, and among the kernels, the linear kernel offered the most
promising results. The confusion matrix is shown in Table 4.1.

Table 4.1 Confusion matrix of SVM on selected peaks

PD NC
PD (predicted) 465

85

NC (predicted)

537
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13

𝑇𝑃+𝑇𝑁

Accuracy: TP+FP+TN+FN = 0.918

4.3

Sensitivity: TP+FN = 0.97

4.4

Specificity: FP+TN = 0.86

4.5

𝑇𝑃

𝑇𝑁

For the random forest, the number of estimators is 100 and entropy was used for the
criterion, and the confusion matrix is described in Table 4.2 and the result for KNN
classification is depicted in Table 4.3.

Table 4.2 Confusion matrix of RF on selected peaks

PD NC
PD (predicted) 369 181
NC (predicted) 121 429
Accuracy: 0.73
Sensitivity: 0.75
Specificity: 0.70

Table 4.3 Confusion matrix of KNN on selected peaks

PD NC
PD (predicted) 300 250
NC (predicted) 102 448
Accuracy: 0.68
Sensitivity: 0.74
Specificity: 0.64
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2.2 Using the Whole Electropherogram

It was realized that due to differences in the speed of reaction between the samples
and FITC, the amplitudes of the peaks can vary across different samples. To tackle this
problem, a new set of samples are derivatized. However, this time the samples were
allowed to sit for 5 days in darkness. The samples went through the same sample treatment,
dilution procedure, and the same running protocol.
Before starting the analysis for the newly acquired dataset, the same moving
average algorithm to suppress the noise is used. Once the filtering with moving average
filter is performed, the baseline correction needs to be carried out. Therefore, after the noise
reduction, the valleys of the signal are detected, and they are used to draw a curve based
on the cubic interpolation of these points. Next, the fitting curve is subtracted from the
signal resulting in baseline correction. Due to changes in experimental uncontrolled
conditions such as temperature, or current variation within different samples run-times, the
peaks migration time could vary, and these time shifts lead to differences in the occurrence
of corresponding peaks across samples. Therefore, it is crucial to perform a signal
alignment algorithm for further analysis. Dynamic time warping (DTW) is used to align
the signals. DTW is a well-known approach that widely has been used to deal with different
retention times in CE analysis [36]. The DTW algorithm performs the alignment by
calculating the distance between a pair of points in two given time series. To perform DTW,
one sample is needed to be the reference for the alignment of the rest of the signals. Once
the signal alignment is performed (Figure 4.5), due to the high resolution of CE and since
the whole electropherogram is utilized for the classification, I investigated the effect of
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reducing the dimension of data on the performance of the models. Principle component
analysis (PCA) is used to extract the most relevant features of the signals in the dataset
[37]. Finally, the random forest algorithm and SVM are used to classify the outcome of
PCA and the preprocessed signals without dimension reduction into two groups of PD and
NC.
Due to the small number of samples, the k-fold cross-validation procedure is used
to reach the most generalized result. The value for k is 11, and therefore in each
observation, 10% of the samples belong to the validation set. To apply the DTW method
on the dataset for alignment, one electropherogram is randomly selected as the reference.
For the PCA, I assigned a variance coefficient of 99% and it is applied on noise reduced,
baseline corrected, and aligned electropherograms. Once the PCA is carried out, the dataset
is transferred to 19 principal components. As can be seen (Figure 4.6), there are
considerable differences in the PD and NC groups. This illustration is based on only the
first three important principal components of the dataset.

39

Amplitude (intensity of light)
Amplitude (intensity of light)

Time(min)

Time(min)
Figure 4.5 a) The samples after noise reduction and baseline correction b) DTW is used to align the
electropherograms; PD (red) and NC (blue)
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Figure 4.6 Sample of PCA implementation on the dataset based on a random reference for alignment; PD (Red) and
NC (green)

The performance of the classification algorithms is evaluated using a loop within
the signals. Due to the selection of different references for the DTW method, a loop is
implemented, and therefore, I can sweep across the dataset and choose each of the
electropherograms as a reference for one time. To consider all features, I studied the
performance of different ML classifiers. Firstly, the classification is carried out based on
the Random Forest (RF) algorithm. To train the RF model, I used 500 decision trees.
Moreover, I deployed the Support Vector Machine (SVM) model on the dataset. For the
SVM model, I used a linear kernel with a C of 100. Lastly, within the loop of different
electropherogram references, the classification is performed by the RF and SVM models
which are deployed to the preprocessed, aligned signals and the PCA version of the dataset.
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The highest accuracy of 94 ± 5 % belongs to the RF model on noise-suppressed, baselinecorrected aligned signals. This is the average accuracy of the classification due to different
electropherogram references along with the standard deviation of the classification
accuracies. The results of SVM improved on the PCA version of signals, compared to the
outcome of the same model without dimension reduction. On the other hand, the PCA did
not improve the accuracy of the RF model and as the result, the performance of the model
dropped to 85 ± 7 %. Since the alignment signal is different, the length of the model input
can vary within the loop. The average length of signals is 61034 and the average number
of features after downsampling and alignment is 6129. The results of this analysis are
thoroughly illustrated in Table 4.4. the values are shown based on the average of different
performances with regard to different DTW references and the standard deviation of them.
The accuracy for each model with different DTW references is calculated by 11-fold cross
validation. For the implementation of the data analysis pipeline, I used Python and Scikitlearn machine learning package.

Table 4.4 Results of different models for electropherogram classification

Algorithm

Accuracy

RF

94.00 ± 5.19 %

PCA-RF

85.12 ± 7.27 %

SVM

91.32 ± 8.43 %

PCA-SVM

93.13 ± 5.77 %

Validity
Sensitivity: 94.84 ± 7.20 %
Specificity: 94.22 ± 5.73 %
Sensitivity: 86.24 ± 8.88 %
Specificity: 85.14 ± 8.32 %
Sensitivity: 92.35 ± 9.27 %
Specificity: 90.89 ± 8.86 %
Sensitivity: 94.93 ± 5.40 %
Specificity: 92.05 ± 7.32 %
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The deep learning model that was originally developed for a different dataset
consisting of electropherograms of eye chamber fluids is used to classify the data. The
same approach for data augmentation was used. However, the accuracy achieved was not
satisfactory. Several steps were taken to tackle the low accuracy such as different
augmentation methods and changing the architecture of the original model, but it did not
improve the results.

3. Conclusion and Discussion

This research shows that using electropherogram signals is a reliable method to
classify PD patients from healthy people. The best result was achieved using the RF on
the whole preprocessed signals for classification of the electropherograms of the PD group
from normal control with an average accuracy of 94 percent. As it was shown, by using a
wider number of peaks, higher accuracy can be achieved since it will help with the adequate
number of features on the model. However, every person has a unique composition of
different components in their blood which reflects their distinctive metabolism. Therefore,
this would lead to having a unique electropherogram for each person. This uniqueness is
the reason why we see the variation of the ML model accuracy with different alignments.
There are some molecules that do not exist among all cases that can be the cause of
electropherograms misalignment, and it has impacts on the accuracy of the machine
learning model. Nevertheless, it has been shown that the highest average classification
accuracy across samples is 94% which proves the hypothesis of this study about the
potential use of CE as a new diagnostic tool in precision medicine. Moreover, this
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classification (PD vs NC) was accomplished without identifying any of the molecules in
the electropherogram, and therefore, the overall pattern of the electropherograms is only
important.
Moreover, this study indicates that even by using a few selected numbers of peaks,
we can distinguish PD samples from the healthy group with an SVM model and reach an
accuracy of 91%. This suggests that if we only use targeted peaks that can be identified by
spiking, we can reach a reliable accuracy and limit the variation that is caused due to
misalignment. It is demonstrated that the RF algorithm does a better classification when
we have a larger number of features due to the model characteristic in building a group of
decision trees compared to SVM which is more applicable for a fewer number of features.
This study demonstrates the feasibility of using plasma samples as a testing method
to diagnose PD. This would help the discovery of PD biomarkers because a chemical
element is reflected in a peak in capillary electrophoresis and by identifying this peak in
CE of PD patients, we can find the indicator of Parkinson's disease. This is not just for an
early and accurate diagnosis since it can also play a role in prognosis, by administrating
that element to the patient in order to maintain a healthy state of metabolism.
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4. Future work

For future study, an internal standard can be added to the samples while they are
being derivatized. This can help the analysis of electropherograms in two ways. First, one
of the problems with the current approach is that the injection system of the CZE can
withdraw a different number of samples at different times. An internal standard such as
fluorescence can be used to scale the electropherogram across all the samples. Since
fluorescence does not interact with any of the molecules inside the samples, its intensity in
the detector signal must stay the same assuming there is a similar amount of fluorescence
in all derivatized samples. Furthermore, an internal standard (IS) can help in aligning the
electropherograms together. It can be exploited to break down the electropherogram into
two parts helping the alignment procedure to find better the corresponding peaks in two
signals.
Another important issue that needs to be considered is the fact that similar diseases
that can have common symptoms such as essential tremor (ET) can be misdiagnosed and
including samples from ET patients to the future work will be helpful for building a
generalized model.
Moreover, identifying the peaks existing in the electropherogram will be very
helpful for both classification problems and also determining the biomarkers that are
associated with Parkinson’s disease. Finding the biological components that affect the PD
condition is important since changing the amount of that components to the normal level
could potentially affect the prognosis of Parkinson’s disease.
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Furthermore, to improve the accuracy of the capillary electrophoresis system, we
need to provide an environment for the system to maintain the temperature inside and
outside the capillary to avoid air bubbles. Also, it is important to build a platform where
the laser hits the capillary so there will be no need for the alignment of the capillary with
the laser light and the amplitude of the signals remains persistent with different times of
running samples.
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